Occupational COPD : what is new and how do we identify and ultimately prevent this disease?

P. Blanc (San Francisco, United States of America)

Source: International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases
Disease area: Airway diseases

WebcastSlide presentation

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Blanc (San Francisco, United States of America). Occupational COPD : what is new and how do we identify and ultimately prevent this disease?. International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Smoking cessation: key for both COPD and cardiovascular disease, but how to manage it?
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017


Chronic diseases like asthma and COPD: do they truly exist?
Source: Eur Respir J 2016; 47: 359-361
Year: 2016


What are the knowledge gaps in COPD that prevent new drug development?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014

How to manage a patient with COPD - early identification and how to prevent progression
Source: ERS Satellites 2021
Year: 2021

Clustering of patients with end-stage chronic diseases by symptoms: a new approach to identify health needs.
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018




How COPD patients understand their disease and what are their future expectations?
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Programme organisation: what and how can we do better?
Source: Annual Congress 2007 - PG20 - Pulmonary rehabilitation: an update according to the new ATS/ERS guidelines
Year: 2007


Improving adherence in chronic airways disease: are we doing it wrongly?
Source: Breathe, 17 (2) 210022; 10.1183/20734735.0022-2021
Year: 2021



Cardiovascular disease and COPD: dangerous liaisons?
Source: Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018
Year: 2018



Cleaning agents and chronic lung disease: does the evidence support a link with COPD?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018


Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


To be or not to be–could it be drug related pulmonary disease?
Source: International Congress 2014 – PG02 Current clinical problems in pulmonology
Year: 2014




Treatment of early lung disease – is it possible? Does it work?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004

Does stress affect the planning of future activities in patients with COPD?
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016


Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015